Tag: Sleep Therapy
In brief: VGM’s new collab, Kalogon’s funding, Medline’s milestone
June 5, 2026HME News Staff
WATERLOO, Iowa — VGM & Associates has launched a collaboration with Resmed to help home medical equipment (HME) providers strengthen their sleep therapy programs. By combining VGM’s expanding Total Sleep Services offering with Resmed’s connected sleep health capabilities, the two companies say they create a more connected path from diagnosis to long-term therapy adherence.
The collaboration brings together VGM’s member community and category expertise with Resmed’s...
Resmed reports 11% increase in revenues for Q2
January 29, 2026HME News Staff
SAN DIEGO – Resmed reported revenue increased 11% to $1.4 billion for its second quarter of fiscal year 2026.
Other financial results:
Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%.
Income from operations increased 18%; non-GAAP income from operations up 19%.
Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81.
Operating cash flow of $340 million.
“Our...
Norco Medical expands presence in Northwest
December 1, 2025HME News Staff
BOISE, Idaho – Norco Medical has acquired Kaysville, Utah-based Petersen Medical, broadening its service offerings and reach across eight states in the Northwest.
Norco Medical expects the acquisition to drive operational excellence and elevate patient experiences.
“We are thrilled to welcome Petersen Medical to the Norco family,” said Norco Inc. President Brent Seward and CEO Nicole Kissler. “Our combined strengths, expertise and...
In brief: Amazon One Medical’s new partner, OIG’s new report, AASM’s new guidelines
October 31, 2025HME News Staff
AVON, Ohio – Amazon One Medical and Cleveland Clinic are expanding access to primary care in Northeast Ohio with the opening of the first of two planned offices in the region.
This first office in Avon, Ohio, will be followed with a second office in Shaker Heights, Ohio, by January 2026.
“Primary care helps patients lead healthier lives,” said Pooja Kamath, MD, medical director of Cleveland Offices, One Medical. “We can...
BetterNight expands Northeast footprint with acquisition of Coastal Sleep and Epoch Sleep Centers
September 18, 2025HME News Staff
SAN DIEGO — BetterNight has acquired Coastal Sleep Diagnostics and Epoch Sleep Centers, two well-established sleep care providers serving communities across the Northeastern United States.
By integrating Coastal and Epoch’s clinical expertise and regional reach with its proven telehealth platform and evidence-based care pathways, BetterNight strengthens its position as a trusted provider of end-to-end sleep care.
“We are thrilled to welcome Coastal and Epoch into...
Viemed reports strong sleep therapy growth, eyes resupply boom ahead
August 8, 2025Theresa Flaherty, Managing Editor
LAFAYETTE, La. – Viemed reported strong growth for its second quarter, with the fastest growth in its sleep division, CEO Casey Hoyt said on a recent earnings call.
During the quarter, the company’s sleep therapy patient census was up 15% sequentially and 51% year-over-year. New patient setups were up 72% year-over-year.
“We're focused on aggressively maintaining this growth trend with eight new sleep areas launched since the beginning of the year,”...
From comfort zone to growth zone: Quality DME’s strategic southern move
June 27, 2025HME News Staff
LORTON, Va. – With a new location set to open in Raleigh, N.C., its first in the state, Quality DME is excited to get “out of its comfort zone,” says President Mike Austin.
The new location, the company’s seventh, is in an area with numerous medical facilities.
“We’ve historically been Maryland and Virginia, so we're kind of breaking barriers heading south,” said Austin. “We think Raleigh is going to be a really great opportunity...
EnsoData raises $20M
June 25, 2025HME News Staff
MADISON, Wis. – EnsoData has received $20 million in Series B financing led by Questa Capital to accelerate adoption of its AI-powered sleep medicine solutions.
“Traditional approaches in sleep medicine have left nearly 80% of patients undiagnosed and, of the 20% that are positively diagnosed, only one in two will be successfully treated,” said Justin Mortara, Ph.D., president and CEO of EnsoData. “We need to expand patient access with simpler and more economic testing...
Apnimed shares positive results for sleep apnea pill
May 19, 2025HME News Staff
CAMBRIDGE, Mass. - Apnimed has announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of AD109 in adults living with mid, moderate and severe OSA and across all weight classes. The SynAIRgy trial met its primary endpoint: mean change from baseline in the apnea-hypopnea index (AHI) at 26 weeks compared to placebo (p=0.001). “Today is a landmark moment for Apnimed and for millions living with OSA who have long struggled with limited...
Sleep therapy: Physician access creates delays
May 16, 2025Liz Beaulieu, Editor
YARMOUTH, Maine – There’s a bottleneck in the sleep therapy process, according to 83% of respondents to a recent HME Newspoll, and physicians are the biggest reason for it, they say.
The largest share of respondents blamed the time it takes to get a referral for a sleep physician as the biggest contributor to the bottleneck (31%), followed by the time it takes to get an initial visit with a primary care physician (25%).
The common theme: physicians.
“Most...